Abstract
This study was performed to investigate the safety and efficacy of the intra-articular infusion of ex vivo expanded autologous bone marrow-derived mesenchymal regenerative medicines (BM-MSC) to a cohort of patients with articular cartilage defects in the hip.
Rodrigo Mardones, Claudio M. Jofré, L. Tobar, José J. Minguell
